Asia-Pacific: Veterinary Medicine Vaccines Market 2024

Veterinary Medicine Vaccines Market Size in Asia-Pacific

The Asia-Pacific veterinary medicine vaccines market stood at $X in 2021, remaining constant against the previous year. The market value increased at an average annual rate of +4.7% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the market attained the maximum level in 2021 and is expected to retain growth in the immediate term.

Veterinary Medicine Vaccines Production in Asia-Pacific

In value terms, veterinary medicine vaccines production dropped to $X in 2021 estimated in export price. The total production indicated a notable increase from 2012 to 2021: its value increased at an average annual rate of +4.6% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +50.4% against 2012 indices. The pace of growth was the most pronounced in 2018 when the production volume increased by 17%. Over the period under review, production attained the maximum level at $X in 2020, and then contracted modestly in the following year.

Veterinary Medicine Vaccines Exports

Exports in Asia-Pacific

In 2021, the amount of vaccines for veterinary medicine exported in Asia-Pacific rose markedly to X tons, with an increase of 12% compared with the previous year's figure. The total export volume increased at an average annual rate of +4.0% from 2012 to 2021; the trend pattern remained consistent, with only minor fluctuations in certain years. The growth pace was the most rapid in 2013 when exports increased by 27%. The volume of export peaked in 2021 and is expected to retain growth in years to come.

In value terms, veterinary medicine vaccines exports soared to $X in 2021. Total exports indicated a prominent expansion from 2012 to 2021: its value increased at an average annual rate of +9.1% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +66.9% against 2013 indices. The pace of growth was the most pronounced in 2013 when exports increased by 31%. The level of export peaked in 2021 and is likely to see gradual growth in the immediate term.

Exports by Country

In 2021, Indonesia (X tons) and China (X tons) represented the largest exporters of vaccines for veterinary medicine in Asia-Pacific, together reaching approx. 45% of total exports. South Korea (X tons) held a 14% share (based on physical terms) of total exports, which put it in second place, followed by New Zealand (9.1%), India (7.6%), Australia (6.2%) and Malaysia (5.2%).

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Malaysia (with a CAGR of +24.1%), while the other leaders experienced more modest paces of growth.

In value terms, the largest veterinary medicine vaccines supplying countries in Asia-Pacific were New Zealand ($X), South Korea ($X) and Australia ($X), with a combined 49% share of total exports.

Among the main exporting countries, South Korea, with a CAGR of +19.2%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Asia-Pacific stood at $X per ton in 2021, increasing by 9% against the previous year. Export price indicated a pronounced expansion from 2012 to 2021: its price increased at an average annual rate of +4.9% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, veterinary medicine vaccines export price increased by +63.0% against 2014 indices. The pace of growth appeared the most rapid in 2017 an increase of 16% against the previous year. The level of export peaked in 2021 and is likely to continue growth in the near future.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Australia ($X per ton), while Indonesia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by New Zealand (+12.9%), while the other leaders experienced more modest paces of growth.

Veterinary Medicine Vaccines Imports

Imports in Asia-Pacific

Veterinary medicine vaccines imports rose notably to X tons in 2021, with an increase of 15% on the year before. The total import volume increased at an average annual rate of +4.7% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2013 with an increase of 30%. Over the period under review, imports reached the peak figure in 2021 and are likely to see gradual growth in the immediate term.

In value terms, veterinary medicine vaccines imports surged to $X in 2021. Total imports indicated resilient growth from 2012 to 2021: its value increased at an average annual rate of +6.8% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +53.2% against 2019 indices. The growth pace was the most rapid in 2013 when imports increased by 28%. Over the period under review, imports hit record highs in 2021 and are likely to see gradual growth in the immediate term.

Imports by Country

In 2021, China (X tons), Vietnam (X tons), Thailand (X tons), Malaysia (X tons), Indonesia (X tons), Pakistan (X tons), the Philippines (X tons), India (X tons), Cambodia (X tons), Bangladesh (X tons), Japan (X tons) and South Korea (X tons) represented the main importer of vaccines for veterinary medicine in Asia-Pacific, constituting 90% of total import.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by India (with a CAGR of +29.7%), while imports for the other leaders experienced more modest paces of growth.

In value terms, China ($X) constitutes the largest market for imported vaccines for veterinary medicine in Asia-Pacific, comprising 30% of total imports. The second position in the ranking was held by Thailand ($X), with a 14% share of total imports. It was followed by Vietnam, with a 10% share.

In China, veterinary medicine vaccines imports expanded at an average annual rate of +10.0% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Thailand (+6.1% per year) and Vietnam (+11.3% per year).

Import Prices by Country

The import price in Asia-Pacific stood at $X per ton in 2021, picking up by 8.2% against the previous year. Over the period from 2012 to 2021, it increased at an average annual rate of +2.0%. The most prominent rate of growth was recorded in 2020 an increase of 22% against the previous year. Over the period under review, import prices hit record highs in 2021 and is expected to retain growth in the near future.

Prices varied noticeably country of destination: the country with the highest price was China ($X per ton), while Cambodia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Philippines (+8.0%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :